Pharmacist
Describe when and how to initiation, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; discontinuation and tapering of opioids; medication therapy management and collaborative practice; and appropriate documentation in medical records.
Describe the etiology and epidemiology of chronic pain.
Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.
Identify West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.
Explain how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-l.
Explain the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.
Describe the best practices for identifying “red flag” patient drug seeking & diversion behaviors.
Explain how to be compliant with federal and state controlled substances laws.
Explain the best practices for working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.
Pharmacy Technician
Identify West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.
Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.
Identify the best practices for the use of opioid medications based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; & discontinuation and tapering of opioids.
Explain how to be compliant with federal and state controlled substance laws
Explain how to ensure that the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment are in place within a pharmacy practice
Describe the etiology and epidemiology of chronic pain.
Explain the best practices for working with patients, prescribers, law enforcement, and other as appropriate, concerning patients suspected of drug seeking behavior and diversion
Describe the best practices for identifying "red flag" patient drug seeking & diversion behaviors
Explain how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-l.
Nurse
Explain how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-l.
Identify West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.
Describe when and how to initiation, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; discontinuation and tapering of opioids; medication therapy management and collaborative practice; and appropriate documentation in medical records.
Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.
Explain how to be compliant with federal and state controlled substances laws.
Describe the etiology and epidemiology of chronic pain.
Describe the best practices for identifying “red flag” patient drug seeking & diversion behaviors.
Explain the best practices for working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.
Explain the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.